IFOSFAMIDE

被引:176
作者
ZALUPSKI, M
BAKER, LH
机构
关键词
D O I
10.1093/jnci/80.8.556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:556 / 566
页数:11
相关论文
共 135 条
[1]  
AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P861
[2]  
AIGENGER HP, 1982, 13TH INT CANC C SEAT
[3]  
ALLEN LM, 1972, CANCER CHEMOTH REP 1, V56, P603
[4]  
ALLEN LM, 1976, CANCER TREAT REP, V60, P451
[5]  
ANDO K, 1981, W JPN J UROL, V43, P1299
[6]  
ANTMAN KH, 1985, CANCER TREAT REP, V69, P499
[7]  
ANTMAN KH, 1987, IN PRESS OCT P INT S
[8]   TREATMENT OF IFOSFAMIDE-INDUCED UROTHELIAL TOXICITY BY ORAL-ADMINISTRATION OF SODIUM 2-MERCAPTOETHANE SULFONATE (MESNA) TO PATIENTS WITH INOPERABLE LUNG-CANCER [J].
ARAUJO, CE ;
TESSLER, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :195-201
[9]  
ARAUJO CE, 1983, 13TH INT C CHEM VIEN
[10]  
BAGLEY CM, 1973, CANCER RES, V33, P226